线 in situ

Zhusheng Huang1,2,3, Rong Gu1, Shiqian Huang2

  • 1State Key Laboratory of Pharmaceutical Biotechnology, Medical School and School of Life Science, Nanjing University, Nanjing, 210093, China.

PubMed
概括

这项研究引入了性加多纳米线,通过增强瘤免疫接种和T细胞反应,显著提高了放射治疗的有效性. 这些纳米线改善了对原发性和转移性瘤的放射性免疫疗法.